Literature DB >> 18480435

Qualitative and quantitative characteristics of rotavirus-specific CD8 T cells vary depending on the route of infection.

Janina Q Jiang1, Xiao-Song He, Ningguo Feng, Harry B Greenberg.   

Abstract

CD8 T-cell response provides an important defense against rotavirus, which infects a variety of systemic locations in addition to the gut. Here we investigated the distribution, phenotype, and function of rotavirus-specific CD8 T cells in multiple organs after rotavirus infection initiated via the intranasal, oral, or intramuscular route. The highest level of virus-specific CD8 T cells was observed in the Peyer's patches of orally infected mice and in the lungs of intranasally infected animals. Very low levels of virus-specific CD8 T cells were detected in peripheral blood or spleen irrespective of the route of infection. Rotavirus-specific CD8 T cells from Peyer's patches of orally infected mice expressed high levels of CCR9, while CXCR6 and LFA-1 expression was associated with virus-specific CD8 T cells in lungs of intranasally infected mice. Oral infection induced the highest proportion of gamma interferon(-) CD107a/b(+) CD8 T cells in Peyer's patches. When equal numbers of rotavirus-specific CD8 T cells were transferred into Rag-1 knockout mice chronically infected with rotavirus, the donor cells derived from Peyer's patches of orally infected mice were more efficient than those derived from lungs of intranasally infected animals in clearing intestinal infection. These results suggest that different routes of infection induce virus-specific CD8 T cells with distinct homing phenotypes and effector functions as well as variable abilities to clear infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480435      PMCID: PMC2446946          DOI: 10.1128/JVI.00450-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  Generation of gut-homing T cells and their localization to the small intestinal mucosa.

Authors:  Bengt Johansson-Lindbom; William W Agace
Journal:  Immunol Rev       Date:  2007-02       Impact factor: 12.988

2.  Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells.

Authors:  Shigeo Koido; Eiichi Hara; Sadamu Homma; Makoto Mitsunaga; Akitaka Takahara; Eijiro Nagasaki; Hidejiro Kawahara; Michiaki Watanabe; Yoichi Toyama; Satoru Yanagisawa; Susumu Kobayashi; Katsuhiko Yanaga; Kiyotaka Fujise; Jianlin Gong; Hisao Tajiri
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

3.  alpha(4)beta(7) independent pathway for CD8(+) T cell-mediated intestinal immunity to rotavirus.

Authors:  N A Kuklin; L Rott; J Darling; J J Campbell; M Franco; N Feng; W Müller; N Wagner; J Altman; E C Butcher; H B Greenberg
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 4.  Rotavirus vaccines: recent developments and future considerations.

Authors:  Juana Angel; Manuel A Franco; Harry B Greenberg
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

Review 5.  Regulation of interferon-gamma during innate and adaptive immune responses.

Authors:  Jamie R Schoenborn; Christopher B Wilson
Journal:  Adv Immunol       Date:  2007       Impact factor: 3.543

Review 6.  The role of the integrin LFA-1 in T-lymphocyte migration.

Authors:  Andrew Smith; Paula Stanley; Kristian Jones; Lena Svensson; Alison McDowall; Nancy Hogg
Journal:  Immunol Rev       Date:  2007-08       Impact factor: 12.988

7.  Extraintestinal rotavirus infections in children with immunodeficiency.

Authors:  M A Gilger; D O Matson; M E Conner; H M Rosenblatt; M J Finegold; M K Estes
Journal:  J Pediatr       Date:  1992-06       Impact factor: 4.406

8.  Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.

Authors:  L Yuan; A Geyer; D C Hodgins; Z Fan; Y Qian; K O Chang; S E Crawford; V Parreño; L A Ward; M K Estes; M E Conner; L J Saif
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity.

Authors:  E J Kunkel; J J Campbell; G Haraldsen; J Pan; J Boisvert; A I Roberts; E C Ebert; M A Vierra; S B Goodman; M C Genovese; A J Wardlaw; H B Greenberg; C M Parker; E C Butcher; D P Andrew; W W Agace
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

10.  Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant.

Authors:  Bengt Johansson-Lindbom; Marcus Svensson; Marc-André Wurbel; Bernard Malissen; Gabriel Márquez; William Agace
Journal:  J Exp Med       Date:  2003-09-08       Impact factor: 14.307

View more
  16 in total

1.  Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18.

Authors:  Benyue Zhang; Benoit Chassaing; Zhenda Shi; Robin Uchiyama; Zhan Zhang; Timothy L Denning; Sue E Crawford; Andrea J Pruijssers; Jason A Iskarpatyoti; Mary K Estes; Terence S Dermody; Wenjun Ouyang; Ifor R Williams; Matam Vijay-Kumar; Andrew T Gewirtz
Journal:  Science       Date:  2014-11-14       Impact factor: 47.728

Review 2.  Migration, maintenance and recall of memory T cells in peripheral tissues.

Authors:  David L Woodland; Jacob E Kohlmeier
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

Review 3.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

4.  Oral exposure to Trypanosoma cruzi elicits a systemic CD8⁺ T cell response and protection against heterotopic challenge.

Authors:  Matthew H Collins; Julie M Craft; Juan M Bustamante; Rick L Tarleton
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

5.  HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice.

Authors:  Andrea S Laimbacher; Laura E Esteban; Alejandro A Castello; Juan C Abdusetir Cerfoglio; Marcelo H Argüelles; Graciela Glikmann; Alejandra D'Antuono; Nora Mattion; Mabel Berois; Juan Arbiza; Monika Hilbe; Elisabeth M Schraner; Michael Seyffert; Christiane Dresch; Alberto L Epstein; Mathias Ackermann; Cornel Fraefel
Journal:  Mol Ther       Date:  2012-06-19       Impact factor: 11.454

6.  CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.

Authors:  Lian Ni Lee; Edward O Ronan; Catherine de Lara; Kees L M C Franken; Tom H M Ottenhoff; Elma Z Tchilian; Peter C L Beverley
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

Review 7.  Immunity to enteric viruses.

Authors:  Ainsley Lockhart; Daniel Mucida; Roham Parsa
Journal:  Immunity       Date:  2022-05-10       Impact factor: 43.474

Review 8.  Guarding the perimeter: protection of the mucosa by tissue-resident memory T cells.

Authors:  L S Cauley; L Lefrançois
Journal:  Mucosal Immunol       Date:  2012-11-07       Impact factor: 7.313

9.  Chemokine gene expression in lung CD8 T cells correlates with protective immunity in mice immunized intra-nasally with Adenovirus-85A.

Authors:  Lian N Lee; Dilair Baban; Edward O Ronan; Jiannis Ragoussis; Peter C L Beverley; Elma Z Tchilian
Journal:  BMC Med Genomics       Date:  2010-10-13       Impact factor: 3.063

10.  Infectious bursal disease virus infection leads to changes in the gut associated-lymphoid tissue and the microbiota composition.

Authors:  Li Li; Tereza Kubasová; Ivan Rychlik; Frederic J Hoerr; Silke Rautenschlein
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.